ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023
Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer.
Murray KorcPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it